PT87124A - Process for preparing 5-substituted quinolone and naphthyridonecarboxylic acid derivatives - Google Patents
Process for preparing 5-substituted quinolone and naphthyridonecarboxylic acid derivativesInfo
- Publication number
- PT87124A PT87124A PT87124A PT8712488A PT87124A PT 87124 A PT87124 A PT 87124A PT 87124 A PT87124 A PT 87124A PT 8712488 A PT8712488 A PT 8712488A PT 87124 A PT87124 A PT 87124A
- Authority
- PT
- Portugal
- Prior art keywords
- preparing
- acid derivatives
- substituted quinolone
- naphthyridonecarboxylic acid
- naphthyridonecarboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873711193 DE3711193A1 (de) | 1987-04-02 | 1987-04-02 | 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT87124A true PT87124A (pt) | 1988-04-01 |
| PT87124B PT87124B (pt) | 1992-07-31 |
Family
ID=6324762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT87124A PT87124B (pt) | 1987-04-02 | 1988-03-30 | Processo para a preparacao de derivados de acidos quinolono- e naftiridonocarboxilicos 5-substituidos |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0284935A1 (pt) |
| JP (1) | JPS63258855A (pt) |
| KR (1) | KR880012593A (pt) |
| CN (1) | CN88101741A (pt) |
| AU (1) | AU1381188A (pt) |
| DD (1) | DD274029A5 (pt) |
| DE (1) | DE3711193A1 (pt) |
| DK (1) | DK180288A (pt) |
| FI (1) | FI881501A7 (pt) |
| HU (1) | HU201050B (pt) |
| IL (1) | IL85943A0 (pt) |
| NO (1) | NO881121L (pt) |
| PT (1) | PT87124B (pt) |
| ZA (1) | ZA882318B (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5591744A (en) * | 1987-04-16 | 1997-01-07 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| JPS649992A (en) * | 1987-06-30 | 1989-01-13 | Dainippon Pharmaceutical Co | 1,8-crosslinked quinolincarboxylic acid derivative, ester thereof and salt thereof |
| US4839355A (en) * | 1987-09-09 | 1989-06-13 | Sterling Drug Inc. | Tricyclic-pyridinylquinoline compounds, their preparation and use |
| US5164392A (en) * | 1987-10-16 | 1992-11-17 | Dainippon Pharmaceutical Co., Ltd. | Quinoline derivatives and antibacterial agent containing them |
| IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
| JPH0228178A (ja) * | 1988-04-23 | 1990-01-30 | Toyama Chem Co Ltd | 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法 |
| AU609974B2 (en) * | 1988-05-18 | 1991-05-09 | Warner-Lambert Company | Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids |
| JPH0674261B2 (ja) * | 1988-06-21 | 1994-09-21 | 塩野義製薬株式会社 | キノロンカルボン酸誘導体 |
| AU5123690A (en) * | 1989-03-13 | 1990-09-13 | Bristol-Myers Squibb Company | 5-substituted-1,4-dihydro-4-oxo-nephthyridine-3-carboxylate antibacterial agents |
| AU5404790A (en) * | 1989-04-26 | 1990-11-16 | Upjohn Company, The | Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents |
| WO1991004972A1 (en) * | 1989-10-06 | 1991-04-18 | Pfizer Inc. | 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents |
| US5385913A (en) * | 1989-10-06 | 1995-01-31 | Pfizer Inc. | 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents |
| DK0525057T3 (da) | 1990-04-18 | 2000-07-31 | Procter & Gamble Pharma | Antimikrobielle quinolonyllactamer |
| DE4032560A1 (de) * | 1990-10-13 | 1992-04-16 | Bayer Ag | 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate |
| FR2681863B1 (fr) * | 1991-09-27 | 1995-02-03 | Rhone Dpc Europ | Solution de sparfloxacine sa preparation et sel la constituant. |
| WO1993013101A1 (fr) * | 1991-12-27 | 1993-07-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Compose de pyridonecarboxylate, son utilisation pharmaceutique et compose spiro |
| US5646163A (en) * | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| TW252107B (pt) * | 1993-08-27 | 1995-07-21 | Hokuriku Pharmacetical Co Ltd | |
| CN1183778A (zh) * | 1995-01-24 | 1998-06-03 | 北陆制药株式会社 | 喹啉羧酸衍生物 |
| DE10108750A1 (de) * | 2001-02-23 | 2002-09-05 | Bayer Ag | Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren |
| JP2006504690A (ja) * | 2002-09-10 | 2006-02-09 | ファイザー・プロダクツ・インク | Ｃｎｓ及びその他の障害の治療に有用なジアザ二環式化合物 |
| SI1666477T1 (sl) | 2003-09-10 | 2013-10-30 | Kyorin Pharmaceutical Co., Ltd. | Derivati 7-(4-substituiran 3-ciklopropilaminometil-1-pirolidinil) kinolonkarboksilne kisline |
| US7897607B2 (en) | 2004-04-07 | 2011-03-01 | Takeda Pharmaceutical Company Limited | Cyclic compounds |
| US8222407B2 (en) | 2007-05-24 | 2012-07-17 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| CN105037388A (zh) * | 2015-08-28 | 2015-11-11 | 安徽环球药业股份有限公司 | 一种安妥沙星的制备方法 |
| CN106674254B (zh) * | 2016-12-21 | 2019-03-15 | 广东省中医院 | 一类喹诺酮羧酸化合物及其中间体、制备方法以及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59137482A (ja) * | 1983-01-26 | 1984-08-07 | Otsuka Pharmaceut Co Ltd | ピロロ〔３，２，１，−ｉｊ〕キノリン−５−カルボン酸誘導体 |
| IE58742B1 (en) * | 1984-07-20 | 1993-11-05 | Warner Lambert Co | Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds |
| US4657913A (en) * | 1985-04-18 | 1987-04-14 | Warner-Lambert Company | Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents |
| AU594983B2 (en) * | 1985-10-29 | 1990-03-22 | Dainippon Pharmaceutical Co. Ltd. | Novel quinoline derivatives and processes for preparation thereof |
| US4977154A (en) * | 1985-12-12 | 1990-12-11 | Warner-Lambert Company | 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents |
| EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
-
1987
- 1987-04-02 DE DE19873711193 patent/DE3711193A1/de not_active Withdrawn
-
1988
- 1988-03-14 NO NO881121A patent/NO881121L/no unknown
- 1988-03-21 EP EP88104452A patent/EP0284935A1/de not_active Withdrawn
- 1988-03-28 AU AU13811/88A patent/AU1381188A/en not_active Abandoned
- 1988-03-29 DD DD88314159A patent/DD274029A5/de not_active IP Right Cessation
- 1988-03-30 DK DK180288A patent/DK180288A/da not_active Application Discontinuation
- 1988-03-30 PT PT87124A patent/PT87124B/pt not_active IP Right Cessation
- 1988-03-30 FI FI881501A patent/FI881501A7/fi not_active Application Discontinuation
- 1988-03-31 KR KR1019880003588A patent/KR880012593A/ko not_active Withdrawn
- 1988-03-31 ZA ZA882318A patent/ZA882318B/xx unknown
- 1988-03-31 IL IL85943A patent/IL85943A0/xx unknown
- 1988-03-31 CN CN198888101741A patent/CN88101741A/zh active Pending
- 1988-04-01 HU HU881619A patent/HU201050B/hu not_active IP Right Cessation
- 1988-04-01 JP JP63078298A patent/JPS63258855A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HU201050B (en) | 1990-09-28 |
| DK180288A (da) | 1988-10-03 |
| JPS63258855A (ja) | 1988-10-26 |
| FI881501A7 (fi) | 1988-10-03 |
| DK180288D0 (da) | 1988-03-30 |
| FI881501A0 (fi) | 1988-03-30 |
| HUT47098A (en) | 1989-01-30 |
| DE3711193A1 (de) | 1988-10-13 |
| ZA882318B (en) | 1988-10-04 |
| AU1381188A (en) | 1988-10-06 |
| EP0284935A1 (de) | 1988-10-05 |
| CN88101741A (zh) | 1988-11-16 |
| PT87124B (pt) | 1992-07-31 |
| DD274029A5 (de) | 1989-12-06 |
| NO881121L (no) | 1988-10-03 |
| IL85943A0 (en) | 1988-09-30 |
| KR880012593A (ko) | 1988-11-28 |
| NO881121D0 (no) | 1988-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT87124A (pt) | Process for preparing 5-substituted quinolone and naphthyridonecarboxylic acid derivatives | |
| FI883249A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi | |
| PT87754A (pt) | Process for the preparation of new amino acid derivatives | |
| PT88596A (pt) | Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas | |
| PT87273A (pt) | Process for preparing substituted quinolones | |
| FI885409A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsiiniamiinijohdannaisten valmistamiseksi | |
| ES540441A0 (es) | Procedimiento de preparar derivados de acidos naftiridin- quinolin- y benzoxazin-carboxilicos | |
| FI880941A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi | |
| FI883050L (fi) | Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi | |
| FI873467A7 (fi) | Menetelmä 5-amino-4-hydroksivaleriaanahappojohdannaisten valmistamiseksi | |
| FI880816A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi | |
| FI893100L (fi) | Analogiamenetelmä asyylideoksiribonukleosidijohdannaisten valmistamiseksi | |
| FI893361L (fi) | Menetelmä ACAT-inhiboivien kinoliinijohdannaisten valmistamiseksi | |
| FI893405L (fi) | Menetelmä kinoloniyhdisteiden valmistamiseksi | |
| PT87153A (pt) | Process for the preparation of acid ribofuranuronic derivatives | |
| FI882909A7 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten furanyylimetyylisubstituoitujen bentsimidatsoli- ja imidatsopyridiinijohdannaisten valmistamiseksi | |
| FI885522A7 (fi) | Kinoliini-karboksyylihappo-boorihappoanhydridejä ja menetelmä niiden valmistamiseksi | |
| FI881525A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi | |
| FI885838A7 (fi) | Menetelmä tioformamidijohdannaisten valmistamiseksi | |
| FI885560A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
| FI885942L (fi) | Propoksibentseenijohdannaisia ja menetelmä niiden valmistamiseksi | |
| FI890723A7 (fi) | Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi | |
| DK375085D0 (da) | Quinolon-carboxylsyre-derivater og fremgangsmaade til fremstilling deraf | |
| YU230788A (en) | Process for obtaining heterocyclic oxophtalizinyl ocetic acid | |
| DK313785D0 (da) | Dihydroorotsyrederivat og fremgangsmaade til fremstilling deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19920122 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19930731 |